Understand the impact of the current national opioid crisis on transplantation in the US
Discuss the benefits/risks of accepting a kidney from a donor with risk factors for HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) compared with remaining on the waitlist
Examine the use and effect of HCV+ kidneys in HCV– recipients in the era of direct-acting antivirals (DAAs)
Discuss the benefits/risks of transplants from HIV+ donors to HIV+ recipients
Speaker
Dorry Segev, MD, PhD, FACS Professor of Surgery and Population Health
Vice Chair of Surgery
New York University